CLASS II Drug recall · Reported 5 Apr 2023 · FDA Enforcement Report

Glimepiride recalled by Direct Rx

Direct Rx is recalling Glimepiride, USP, distributed nationwide in the US. The recall was initiated on 13 Mar 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesa) [30 count bottles] Lot, expiry: 07MA2208, exp 5/31/2024 b) [90 count bottles] Lot, expiry: 09AU2128 , exp 1/31/2024; 28JY2102 , exp 1/31/2024; 06AU2103 , exp 1/31/2024 ; 03JA2210 , exp 1/31/2024 ; 14JY2114 , exp 1/31/2024 ; 05NO2106 , exp 2/29/2024 ; 13OC2118 , exp 2/29/2024 ; 08DE2121 , exp 2/29/2024 ;
Quantity recalled30 count: 4 bottles; 90 count: 172 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0480-2023
FDA event ID
91921
Recalling firm
Direct Rx, Dawsonville, GA
Classification
Class II
Status
Terminated
Recall initiated
13 Mar 2023
FDA classified
24 Mar 2023
Reported
5 Apr 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter

Timeline

13 Mar 2023Recall initiated by company
24 Mar 2023Classified by FDA+11 days
5 Apr 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

cGMP deviations

Product as listed by the FDA

Glimepiride, USP, 1 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0723-30; b) 90-count bottle, NDC 61919-0723-90 Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Is Glimepiride, USP recalled?

Yes. Direct Rx recalled Glimepiride, USP on 13 Mar 2023. The recall is Class II and its status is Terminated. Recall number D-0480-2023.

Why was it recalled?

cGMP deviations

Which lots are affected?

a) [30 count bottles] Lot, expiry: 07MA2208, exp 5/31/2024 b) [90 count bottles] Lot, expiry: 09AU2128 , exp 1/31/2024; 28JY2102 , exp 1/31/2024; 06AU2103 , exp 1/31/2024 ; 03JA2210 , exp 1/31/2024 ; 14JY2114 , exp 1/31/2024 ; 05NO2106 , exp 2/29/2024 ; 13OC2118 , exp 2/29/2024 ; 08DE2121 , exp 2/29/2024 ;

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Direct Rx

All 37